Dr Mohammed AlHilali is a Consultant Clinical Oncologist at Newcastle Hospital’s Northern Centre for Cancer Care.
He specialises in the treatment of upper gastrointestinal cancers, including oesophageal and stomach cancers, pancreatic and biliary tract cancers, neuroendocrine tumours and rarer cancers.
His clinical expertise includes radiotherapy, chemotherapy, targeted treatments and advanced radiotherapy techniques, including stereotactic ablative radiotherapy (SABR).
Dr AlHilali is the trust lead for Neuroendocrine and Rarer Cancers and is actively involved in medical education and training. He is also a Training Programme Director for Clinical Oncology in the North East of England.
He is committed to providing compassionate, evidence-based cancer care, helping patients understand their treatment options and make informed decisions about their care.